FIELD: medicine.
SUBSTANCE: invention relates to application of erythropoetin and analogs thereof (darbepoetin alpha, modified erythropoetin, glycolizied erythropoetin conjugated with polyethylene glycol) to treating disturbances of iron distribution in diabetes. Disclosed are appropriate method for treatment and drug. It is demonstrated that patients suffering from diabetes have high susceptibility to disturbances of iron distribution at normal iron concentration in organism. Subdermal application of erythropoetin in dose of 150 U/kg suppresses this disturbance.
EFFECT: new method for erythropoetin application.
17 cl, 2 dwg, 1 ex
| Title | Year | Author | Number |
|---|---|---|---|
| NEW APPLICATION OF ERYTHROPOIETIN IN HEART DISEASES | 2003 |
|
RU2324494C2 |
| TREATMENT OF NEURODEGENERATIVE DISORDERS | 2006 |
|
RU2467761C2 |
| NOVEL PHARMACEUTICAL COMPOSITION | 2001 |
|
RU2281116C2 |
| METHOD OF PURIFYING PEGYLATED ERYTHROPOIETIN | 2011 |
|
RU2566267C2 |
| CONJUGATES OF ERYTHROPOIETIN AND POLYETHYLENE GLYCOL, PHARMACEUTICAL COMPOSITIONS (VARIANTS), METHOD FOR PROPHYLACTIC AND/OR THERAPEUTIC TREATMENT OF DISTURBANCES AND METHOD FOR PREPARING CONJUGATE OR COMPOSITION | 2000 |
|
RU2232163C2 |
| IMPROVED METHOD FOR PHYSIOLOGICALLY ACTIVE POLYPEPTIDE CONJUGATE PRODUCTION | 2013 |
|
RU2639256C2 |
| ERYTHROPOETIN CONJUGATED WITH POLYETHYLENE GLYCOL | 2010 |
|
RU2433134C1 |
| CHROMATOGRAPHIC METHODS | 2008 |
|
RU2464066C2 |
| SITE-SPECIFIC INSULIN CONJUGATE | 2014 |
|
RU2677800C2 |
| CONJUGATE OF GLYCOPROTEIN, POSSESSING ERYTHROPOIETIN ACTIVITY, WITH POLY-1,4-ETHYLENEPIPERAZINE N-OXIDE DERIVATIVES (VERSIONS), PHARMACEUTICAL COMPOSITION AND METHOD OF CONJUGATE OBTAINING | 2013 |
|
RU2556378C2 |
